arrow
V

Velia Cassano

department of medical and surgical sciences
H指数:16
被引数:822

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Oral semaglutide vs DPP-4 inhibitors in reducing risk of cognitive impairment in elderly patients with HFpEF and obesity

奥马帕利口服剂与DPP-4抑制剂在降低老年HFpEF合并肥胖患者认知障碍风险方面的比较

2026-08-200
OAAI
Circulating uric acid is independently associated with MASLD prevalence and non-invasive advanced fibrosis risk stratification in a Caucasian T2DM cohort

循环尿酸与白人2型糖尿病队列中MASLD患病率及非侵入性晚期肝纤维化风险分层独立相关

2026-07-110
OAAI
Reply to Yavuz, S. Comment on “Martire et al. Prognostic Role of High-Sensitivity C-Reactive Protein/Albumin Ratio in Heart Failure Patients. Biomedicines 2026, 14, 748”

回复 Yavuz, S. 关于“Martire 等人。高敏C反应蛋白/白蛋白比值在心力衰竭患者中的预后作用。Biomedicines 2026, 14, 748”的评论

2026-06-040
OAAI
Association of Vericiguat with Improvement in Functional Abilities and Comprehensive Geriatric Assessment in Elderly Patients with Worsening Heart Failure

维利卡格他(Vericiguat)与老年患者心功能恶化患者功能能力改善及综合老年评估的关联

2026-03-120
OAAI
Correction: Prognostic role of sarcopenia in heart failure patients

更正:肌少症在心力衰竭患者中的预后作用

2026-02-280
OAAI
Risk of coronary artery disease in intermediate hyperglycemia and type 2 diabetes defined by 1-hour post-load glucose levels according to the new IDF criteria

根据新IDF标准,以1小时负荷后血糖水平定义的中间高血糖和2型糖尿病患者的冠状动脉疾病风险

2026-01-110
OAAI
Prognostic role of sarcopenia in heart failure patients

肌肉减少症在心力衰竭患者中的预后作用

2025-10-300
OAAI
Cathepsin K: a novel association with glucose intolerance, insulin resistance, and subclinical atherosclerosis in T2DM

组织蛋白酶K:与2型糖尿病中的葡萄糖不耐受、胰岛素抵抗和亚临床动脉粥样硬化的新型关联

2025-10-030
OAAI
Possible correlation between Triglyceride/HDL ratio and subclinical myocardial damage in patients with cardiovascular risk factors

甘油三酯/高密度脂蛋白比值与心血管风险因素患者亚临床心肌损伤之间可能的关联

2025-08-280
OAAI